Health & Wellness

Fitness 19 Guide: How to Fit Exercise Into a Busy Schedule

Temecula – October 28, 2026 -- Fitness 19 has released "Tips for Fitting Fitness Into Your Busy Schedule," a resource that explains why staying active matters and how to work exercise into a packed day.

Regular activity supports body and mind

According to the resource, staying active keeps the body healthy and strong. It lists several benefits: managing weight, improving mental health, lowering the risk of cardiovascular disease, strengthening muscles and improving bone density.

Those benefits apply now and later. The long-term effects of not prioritizing fitness become clearer as a person ages.

Enjoyable, flexible routines make consistency easier

Once fitness is part of a daily routine, consistency gets easier. To build it in, Fitness 19 recommends choosing an activity you enjoy, staying reasonable about both time and expected results, and keeping your schedule flexible.

Drug-Free Light Therapy for Psoriasis Arrives in Katy

Houston – October 28, 2026 -- Houston-area patients with psoriasis, vitiligo or eczema can now get medically supervised, drug-free Narrowband UVB light therapy at Array Skin Therapy's new clinic at 11211 Katy Freeway, Suite 450, Houston, TX 77079.

The clinic treats three chronic skin conditions with targeted UV light

Narrowband UVB (NB-UVB) phototherapy uses carefully controlled wavelengths of ultraviolet light to target inflammatory processes in the skin. Unlike systemic medications, which can affect multiple systems in the body, it delivers treatment directly to affected skin. Array describes it as a non-invasive alternative or complement to traditional medical therapies.

Korean Skincare Brand FULLY Lands in 580+ U.S. Sephora Stores

SEOUL – October 28, 2026 -- Korean vegan skincare brand FULLY is now sold at more than 580 Sephora stores across the U.S. and online, with six products available since August 20, 2026.

The rollout is part of the OLIVE YOUNG K-Beauty Edit at Sephora. OLIVE YOUNG, which the source describes as Korea's leading beauty and lifestyle retailer, curated the assortment to introduce Korean beauty brands to North American shoppers. For FULLY, it is the largest brick-and-mortar expansion in the U.S. so far.

A 3.5-million-unit clay cleanser leads the lineup

The headliner is the Green Tomato Clay Mask Cleanser, a 2-in-1 product that has sold more than 3.5 million units worldwide. The creamy clay is applied as a mask, then turns into a rich foam with water to remove excess sebum and pore buildup.

Cardi B featured the product on TikTok in 2025. That same year, Women's Health named it Best Clay Mask in its 2025 Skincare Awards.

Miami Beach's Mount Sinai Ranks #1 in Florida for GI Surgery

MIAMI BEACH – October 28, 2026 -- Patients in South Florida choosing a hospital for stomach and bowel surgery now have a data point: Mount Sinai Medical Center ranks first in the state for gastrointestinal surgery, according to Healthgrades, the site Americans use to search for doctors and hospitals.

Mount Sinai lands in the top 5 in Florida across six categories

Beyond its #1 spot in gastrointestinal surgery, the hospital placed #3 for cranial neurosurgery. It ranked #5 for cardiac care, cardiology services, neurosciences and stroke care.

Mount Sinai has been named one of America's 100 Best Hospitals, the top 2% nationally, for three consecutive years. It also earned four specialty distinctions: Cardiac Care (2027), Pulmonary Care (2026-2027), Stroke Care (2024-2027) and Gastrointestinal Surgery (2024-2027).

Why a Hair Dryer's Hum Can Help You Fall Asleep

Mainz – October 28, 2026 -- The drone of a vacuum cleaner, hair dryer or extractor hood helps some people wind down and fall asleep, while the same noises wear on others. Eberhard Schmidt, president of the Bundesinnung der Hörakustiker (biha), explains the phenomenon known as ASMR (Autonomous Sensory Meridian Response).

Monotone hums can calm babies and adults

Parents may know the effect: a baby who refuses to sleep can settle when the extractor hood runs. Some adults also use the sound of a vacuum cleaner or hair dryer to switch off and doze off. According to biha, this can go so far that the sound eventually becomes a necessary sleep aid.

ASMR brings a tingle that starts on the scalp

Acoustic, visual and tactile stimuli can all trigger a pleasant tingling that usually begins on the scalp and spreads across the body like a shiver. ASMR is the subject of scientific study and has seen a hype in recent years, especially on social media.

Dry Salt Inhalation: KLAFS Brings Sea Air Home

Schwäbisch Hall – October 28, 2026 -- KLAFS offers the patented Microsalt SaltProX, a compact dry-salt inhalation system that works at home or on the road and is meant to support the airways through the cold season.

Cold and dry air strain the airways in autumn and winter

The airways clear themselves with a thin layer of mucus that binds particles and pathogens. Millions of tiny cilia move this film toward the throat, where it is carried away. Cold outdoor air and dry heated air can dry out the mucous membranes and disrupt this process. When mucus becomes too thick, it is removed less effectively.

Microsalt SaltProX turns rock salt into microscopic particles

The system grinds natural rock salt into microscopic particles and disperses them in the room air. Inhaled particles settle on the mucous membranes and can help loosen thick mucus and ease its removal. Unlike steam inhalation, dry salt adds no extra moisture to the air.

Philips Lumea 9900 Pro Brings Talking Guidance to At-Home IPL

AMSTERDAM – October 28, 2026 -- The Philips Lumea 9900 Pro, which Philips describes as the first at-home IPL device with audio feedback and motion guidance that talks to you, is now on sale at a recommended retail price of EUR 799.99. The launch arrives alongside three beauty technology trends outlined by a dermatologist, a foresight analyst and a wellness founder.

Shoppers expect guidance, not just information

Mintel research cited by Philips shows that 62% of U.S. beauty and personal care buyers are interested in hyper-personalized products. Alice Crossley, Principal Strategic Foresight Analyst at The Future Laboratory, says consumers now expect beauty technology to respond in real time and explain why it recommends a given step. Brands that turn complex science into practical, personal advice will shape the next wave of innovation, she says.

FDA Clears Dual-Route Gene Therapy SGT-212 for Friedreich's Ataxia

Boston – October 28, 2026 -- People living with Friedreich's ataxia (FA) have a new gene therapy candidate heading toward human testing: Solid Biosciences says the FDA has cleared its Investigational New Drug (IND) application for SGT-212, with a Phase 1b trial planned for the second half of 2025.

SGT-212 attacks FA through two delivery routes

The company describes SGT-212 as the first gene therapy in the industry to use a dual route of administration. It delivers full-length frataxin protein in two ways:

Duchenne Gene Therapy SGT-003 Shows Positive Interim Trial Data

United States – October 28, 2026 -- Solid Biosciences has dosed 40 participants with its Duchenne gene therapy SGT-003 and reported positive interim safety and biomarker data from the ongoing Phase 1/2 INSPIRE DUCHENNE trial. The company presented the update at the 2026 MDA Clinical & Scientific Conference.

The therapy delivers a shortened dystrophin protein

SGT-003 delivers microdystrophin, a shortened version of dystrophin designed to help support and protect muscle cells during movement. The data show robust microdystrophin expression. They also show restoration of beta-sarcoglycan and nNOS, proteins that normally work with dystrophin in the dystrophin-associated protein complex (DAPC), the muscle cell support system.

Duchenne Gene Therapy Trial Expands to 43 Participants

United States – October 27, 2026 -- Solid Biosciences has expanded its INSPIRE DUCHENNE gene therapy trial to 43 participants and now accepts children aged 4 to under 12, up from the previous range of 4 to under 8.

Three participants dosed with no serious adverse events

INSPIRE DUCHENNE is a first-in-human, multicenter, Phase 1/2 open-label study. It tests the safety, tolerability and efficacy of a single intravenous infusion of SGT-003, a next-generation AAV gene therapy candidate, in ambulant boys with Duchenne.

Three participants have been dosed so far. According to Solid, SGT-003 has been well tolerated to date, and no serious adverse events have been reported. The company plans to share safety, expression and biomarker data from these first three patients, along with a trial update, in the first quarter of 2025.